Partnership between Oklo and Atomic Alchemy for isotope production

Oklo Inc. and Atomic Alchemy launch a partnership to increase the production of industrial and medical isotopes, essential in various sectors including cancer treatment.

Share:

Partenariat Oklo Atomic Alchemy Isotope

Comprehensive energy news coverage, updated nonstop

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access • Archives included • Professional invoice

OTHER ACCESS OPTIONS

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

FREE ACCOUNT

3 articles offered per month

FREE

*Prices are excluding VAT, which may vary depending on your location or professional status

Since 2021: 35,000 articles • 150+ analyses per week

Against a backdrop of worldwide shortages of medical and industrial isotopes, Oklo Inc. and Atomic Alchemy announce strategic partnership to increase production of essential isotopes. This partnership leverages Oklo’s capabilities in fast fission technology and nuclear fuel recycling with Atomic Alchemy’s expertise in isotope production. Together, they plan to build and operate fast reactors that will not only be a source ofclean energy production, but also a platform for the production of vital isotopes for medical diagnostics, cancer treatment and industrial applications.

Technology and innovation at the heart of the partnership

Oklo’s fast reactors and advanced fuel recycling processes form the technological basis of this partnership. These technologies will enable the production of a wide range of isotopes, including those currently in critical short supply, such as those used in radioisotope thermoelectric generators and advanced cancer therapies. Oklo uses a reactor technology that optimizes the use of nuclear fuel and minimizes waste, while increasing the efficiency of isotope production.

Economic and security implications

This partnership is strategic not only from a technological point of view, but also from an economic and security one. By increasing domestic isotope production, the USA could reduce its dependence on foreign sources, often located in geopolitically unstable areas. This initiative is all the more relevant given that global demand for medical isotopes is rising steadily, fuelled by advances in cancer diagnosis and treatment technologies.

Challenges and prospects

The partnership between Oklo and Atomic Alchemy is not without its challenges. The complexity of isotope production requires considerable investment in research and development, as well as strict regulatory safeguards to ensure the safety and efficacy of the isotopes produced. However, the heads of both companies, Jacob DeWitte of Oklo and Thomas Eiden of Atomic Alchemy, are confident in their ability to overcome these obstacles thanks to their combined expertise and the support of their strategic and financial partners.
The partnership between Oklo and Atomic Alchemy is a bold step forward in securing the supply of isotopes vital to many sectors. It represents not only a technological breakthrough, but also a strategic initiative that could redefine energy production and public health standards in the United States.

French developer Newcleo launches a joint venture with Nextchem through a EUR70 mn contract to design the conventional island of its upcoming 200 MW modular nuclear reactors.
NANO Nuclear strengthens its North American strategy by acquiring Global First Power in Canada, securing regulatory rights for its KRONOS MMR™ project at Chalk River.
South Korea becomes the first country to submit a safeguards technical report to the IAEA for a small modular reactor, setting a precedent for early integration of non-proliferation requirements in nuclear design.
The Environmental Authority criticises the lack of key data on health risks, chemical discharges and construction safety for EDF's two upcoming EPR2 reactors in Seine-Maritime.
Brazil and China have concluded a three-year agreement to secure access to essential radioisotopes for the medical, industrial and scientific sectors, with no financial exchange between the parties.
US-based developer Last Energy will deploy its first domestic microreactor at Texas A&M-RELLIS, marking a strategic step in the advanced modular reactor race.
PGE acquires ZE PAK's stake in the joint venture responsible for developing Poland’s second nuclear site, consolidating a strategic asset within its energy portfolio.
Amazon unveils new visuals of its upcoming nuclear site, marking a key step in its partnership with X-energy to deploy up to 960 MW of modular nuclear capacity in Washington state.
Canadian uranium producer NexGen Energy has completed a A$1bn ($639mn) equity raise split between North American and Australian markets to support the development of its Rook I project.
Tokyo Electric Power Company Holdings is examining the permanent closure of units 1 and 2 at the Kashiwazaki-Kariwa nuclear power plant, the oldest at the site, while continuing efforts to restart unit 6.
The formal expiration of the 2015 nuclear deal with Iran comes as international sanctions have already been reinstated and diplomatic negotiations remain stalled.
Oklo, newcleo and Blykalla partner to develop advanced nuclear fuel infrastructure in the United States, backed by a planned $2bn investment.
enCore Energy has identified three new uranium roll fronts at its Alta Mesa project, with ongoing drilling aimed at defining their extent and accelerating development work.
California-based Radiant will build its first microreactor production facility in Oak Ridge, on a former Manhattan Project site, with production targeted at 50 units per year by 2028.
EDF restarted the Flamanville EPR reactor after repairing non-compliant valves, delaying the target of reaching full power output of 1,620 MW until the end of autumn.
Nano Nuclear and the University of Illinois will begin drilling operations for the KRONOS MMR™ reactor on October 24, marking a key step toward commercialisation of the nuclear project on the Urbana-Champaign campus.
Natura Resources is finalising construction of the MSR-1, an advanced liquid-fuel nuclear reactor, with a planned launch in 2026 on the Abilene Christian University campus.
JPMorganChase commits $10bn in direct investments as part of a $1.5tn plan to boost energy independence and strategic technologies, including next-generation nuclear power.
A roadmap under development aims to establish regulatory and technical foundations for the deployment of small modular reactors, with the goal of strengthening national energy security and attracting private capital.
EDF adjusts its 2025 nuclear production forecast to between 365 and 375 TWh, supported by the performance of its industrial programme START 2025 focused on maintenance efficiency.

All the latest energy news, all the time

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access - Archives included - Pro invoice

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

*Prices shown are exclusive of VAT, which may vary according to your location or professional status.

Since 2021: 30,000 articles - +150 analyses/week.